Cargando…

Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation

Purpose: This study aimed to explore underlying action mechanism of Wu-Tou decoction (WTD) in rheumatoid arthritis (RA) through network pharmacology prediction and experimental verification. Methods: Chemical compounds and human target proteins of WTD as well as RA-related human genes were obtained...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qingqing, Zheng, Kang, Fan, Danping, Zhao, Yukun, Li, Li, Bian, Yanqin, Qiu, Xuemei, Liu, Xue, Zhang, Ge, Ma, Chaoying, He, Xiaojuan, Lu, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414545/
https://www.ncbi.nlm.nih.gov/pubmed/28515692
http://dx.doi.org/10.3389/fphar.2017.00230
_version_ 1783233395737755648
author Guo, Qingqing
Zheng, Kang
Fan, Danping
Zhao, Yukun
Li, Li
Bian, Yanqin
Qiu, Xuemei
Liu, Xue
Zhang, Ge
Ma, Chaoying
He, Xiaojuan
Lu, Aiping
author_facet Guo, Qingqing
Zheng, Kang
Fan, Danping
Zhao, Yukun
Li, Li
Bian, Yanqin
Qiu, Xuemei
Liu, Xue
Zhang, Ge
Ma, Chaoying
He, Xiaojuan
Lu, Aiping
author_sort Guo, Qingqing
collection PubMed
description Purpose: This study aimed to explore underlying action mechanism of Wu-Tou decoction (WTD) in rheumatoid arthritis (RA) through network pharmacology prediction and experimental verification. Methods: Chemical compounds and human target proteins of WTD as well as RA-related human genes were obtained from TCM Database @ Taiwan, PubChem and GenBank, respectively. Subsequently, molecular networks and canonical pathways presumably involved in the treatment of WTD on RA were generated by ingenuity pathway analysis (IPA) software. Furthermore, experimental validation was carried out with MIP-1β-induced U937 cell model and collagen induced arthritis (CIA) rat model. Results: CCR5 signaling pathway in macrophages was shown to be the top one shared signaling pathway associated with both cell immune response and cytokine signaling. In addition, protein kinase C (PKC) δ and p38 in this pathway were treated as target proteins of WTD in RA. In vitro experiments indicated that WTD inhibited MIP-1β-induced production of TNF-α, MIP-1α, and RANTES as well as phosphorylation of CCR5, PKC δ, and p38 in U937 cells. WTD treatment maintained the inhibitory effects on production of TNF-α and RANTES in MIP-1β-induced U937 cells after CCR5 knockdown. In vivo experiments demonstrated that WTD ameliorated symptoms in CIA rats, decreased the levels of IL-1β, IL-2, IL-6, TNF-α, MIP-1α, MIP-2, RANTES, and IP-10 in serum of CIA rats, as well as mRNA levels of MIP-1α, MIP-2, RANTES, and IP-10 in ankle joints of CIA rats. Furthermore, WTD also lowered the phosphorylation levels of CCR5, PKC δ and p38 in both ankle joints and macrophages in ankle joints from CIA rats. Conclusion: It was demonstrated in this research that WTD played a role in inhibiting inflammatory response in RA which was closely connected with the modulation effect of WTD on CCR5 signaling pathway in macrophages.
format Online
Article
Text
id pubmed-5414545
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54145452017-05-17 Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation Guo, Qingqing Zheng, Kang Fan, Danping Zhao, Yukun Li, Li Bian, Yanqin Qiu, Xuemei Liu, Xue Zhang, Ge Ma, Chaoying He, Xiaojuan Lu, Aiping Front Pharmacol Pharmacology Purpose: This study aimed to explore underlying action mechanism of Wu-Tou decoction (WTD) in rheumatoid arthritis (RA) through network pharmacology prediction and experimental verification. Methods: Chemical compounds and human target proteins of WTD as well as RA-related human genes were obtained from TCM Database @ Taiwan, PubChem and GenBank, respectively. Subsequently, molecular networks and canonical pathways presumably involved in the treatment of WTD on RA were generated by ingenuity pathway analysis (IPA) software. Furthermore, experimental validation was carried out with MIP-1β-induced U937 cell model and collagen induced arthritis (CIA) rat model. Results: CCR5 signaling pathway in macrophages was shown to be the top one shared signaling pathway associated with both cell immune response and cytokine signaling. In addition, protein kinase C (PKC) δ and p38 in this pathway were treated as target proteins of WTD in RA. In vitro experiments indicated that WTD inhibited MIP-1β-induced production of TNF-α, MIP-1α, and RANTES as well as phosphorylation of CCR5, PKC δ, and p38 in U937 cells. WTD treatment maintained the inhibitory effects on production of TNF-α and RANTES in MIP-1β-induced U937 cells after CCR5 knockdown. In vivo experiments demonstrated that WTD ameliorated symptoms in CIA rats, decreased the levels of IL-1β, IL-2, IL-6, TNF-α, MIP-1α, MIP-2, RANTES, and IP-10 in serum of CIA rats, as well as mRNA levels of MIP-1α, MIP-2, RANTES, and IP-10 in ankle joints of CIA rats. Furthermore, WTD also lowered the phosphorylation levels of CCR5, PKC δ and p38 in both ankle joints and macrophages in ankle joints from CIA rats. Conclusion: It was demonstrated in this research that WTD played a role in inhibiting inflammatory response in RA which was closely connected with the modulation effect of WTD on CCR5 signaling pathway in macrophages. Frontiers Media S.A. 2017-05-03 /pmc/articles/PMC5414545/ /pubmed/28515692 http://dx.doi.org/10.3389/fphar.2017.00230 Text en Copyright © 2017 Guo, Zheng, Fan, Zhao, Li, Bian, Qiu, Liu, Zhang, Ma, He and Lu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Guo, Qingqing
Zheng, Kang
Fan, Danping
Zhao, Yukun
Li, Li
Bian, Yanqin
Qiu, Xuemei
Liu, Xue
Zhang, Ge
Ma, Chaoying
He, Xiaojuan
Lu, Aiping
Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
title Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
title_full Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
title_fullStr Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
title_full_unstemmed Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
title_short Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
title_sort wu-tou decoction in rheumatoid arthritis: integrating network pharmacology and in vivo pharmacological evaluation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414545/
https://www.ncbi.nlm.nih.gov/pubmed/28515692
http://dx.doi.org/10.3389/fphar.2017.00230
work_keys_str_mv AT guoqingqing wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT zhengkang wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT fandanping wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT zhaoyukun wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT lili wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT bianyanqin wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT qiuxuemei wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT liuxue wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT zhangge wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT machaoying wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT hexiaojuan wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation
AT luaiping wutoudecoctioninrheumatoidarthritisintegratingnetworkpharmacologyandinvivopharmacologicalevaluation